Single-Cell Genome Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030

Single-Cell Genome Sequencing Trends and Forecast

The future of the global single-cell genome sequencing market looks promising with opportunities in the circulating cells, cell differentiation/reprogramming, genomic variation, and subpopulation characterization markets. The global single-cell genome sequencing market is expected to grow with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are chronic illnesses including cancer, diabetes, and arthritis are becoming more common, advanced technology and latest collaborations, and growing number of elderly people.

A more than 150-page report is developed to help in your business decisions.

Single-Cell Genome Sequencing by Segment

The study includes a forecast for the global single-cell genome sequencing by product type, workflow, application, end use, and region.

Single-Cell Genome Sequencing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Reagents

Single-Cell Genome Sequencing Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

• Genomic Analysis
• Single Cell Isolation
• Sample Preparation

Single-Cell Genome Sequencing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Circulating Cells
• Cell Differentiation/Reprogramming
• Genomic Variation
• Subpopulation Characterization
• Others

Single-Cell Genome Sequencing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Academic & Research Laboratories
• Biotechnology & Biopharmaceutical Companies
• Clinics
• Others

Single-Cell Genome Sequencing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Single-Cell Genome Sequencing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies single-cell genome sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the single-cell genome sequencing companies profiled in this report include-

• Bio-Rad Laboratories
• 10X Genomics
• Novogene
• Fluidigm
• F. Hoffmann-La-Roche
• Illumina
• Oxford Nanopore Technologies
• Pacific Biosciences
• Thermo Fisher Scientific
• Qiagen

Single-Cell Genome Sequencing Market Insights

Lucintel forecasts that instruments will remain the largest segment over the forecast period due to embracing of cutting-edge instruments and solutions.

Within this market, circulating cells will remain the largest segment due to growing utilization of circulating tumor cells.

North America will remain the largest region over the forecast period due to rising prevalence of cancer and other chronic ailments.

Features of the Global Single-Cell Genome Sequencing Market

Market Size Estimates: Single-cell genome sequencing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Single-cell genome sequencing market size by various segments, such as by product type, workflow, application, end use, and region in terms of value ($B).

Regional Analysis: Single-cell genome sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product type, workflow, application, end use, and regions for the single-cell genome sequencing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the single-cell genome sequencing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for single-cell genome sequencing market?

Answer: The global single-cell genome sequencing market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the single-cell genome sequencing market?

Answer: The major drivers for this market are chronic illnesses including cancer, diabetes, and arthritis are becoming more common, advanced technology and latest collaborations, and growing number of elderly people.

Q3. What are the major segments for single-cell genome sequencing market?

Answer: The future of the single-cell genome sequencing market looks promising with opportunities in the circulating cells, cell differentiation/reprogramming, genomic variation, and subpopulation characterization markets.

Q4. Who are the key single-cell genome sequencing market companies?

Answer: Some of the key single-cell genome sequencing companies are as follows.

• Bio-Rad Laboratories
• 10X Genomics
• Novogene
• Fluidigm
• F. Hoffmann-La-Roche
• Illumina
• Oxford Nanopore Technologies
• Pacific Biosciences
• Thermo Fisher Scientific
• Qiagen

Q5. Which single-cell genome sequencing market segment will be the largest in future?

Answer: Lucintel forecasts that instruments will remain the largest segment over the forecast period due to embracing of cutting-edge instruments and solutions.

Q6. In single-cell genome sequencing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to rising prevalence of cancer and other chronic ailments.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the single-cell genome sequencing market by product type (instruments and reagents), workflow (genomic analysis, single cell isolation, and sample preparation), application (circulating cells, cell differentiation/reprogramming, genomic variation, subpopulation characterization, and others), end use (academic & research laboratories, biotechnology & biopharmaceutical companies, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?